Cytiva and Pall Life Sciences – Privacy Update for Customers and Partners

News Article

July 05, 2023

Due to the fact that Pall Life Sciences (previously part of Pall) and Cytiva operate now (due to the merger) as one business under the Cytiva brand:
   • Precision NanoSystems is now part of Cytiva;
   • your personal data (in case they were previously processed by Pall within Pall Life Sciences) may have been shared by Pall with Cytiva for the purposes specified     below.

Cytiva and Pall Life Sciences (presently Cytiva) take measures to ensure that your personal data is protected. The basis of processing your personal data for purposes specified below is the legitimate interest to grow our business.

I. Processing purposes
In case your personal data were previously processed by Pall within Pall Life Sciences (presently Cytiva), as part of the merging process, Pall may have shared your personal data with Cytiva, and now Cytiva further processes your personal data to enable Cytiva present organization. The detailed purposes include:
   • Aligning our processes;
   • Setting up common systems and applications;
   • Taking pre-sale activities including contact sharing;
   • Common offers and contracting;
   • Maintaining customer profiles;
   • Processing current and historical order information, managing and validating sales.

II. Additional information
You can learn more about your rights and how to exercise them, as well as about how Cytiva process your personal data (also in respect of any data transfers)[here]
You can find Pall privacy policy [here]

III. Contact Us
If you have any data privacy related questions or concerns regarding this process, you may reach out to the Platform Privacy Leader at


Press Release

Precision NanoSystems, a provider of innovative tools for the development and manufacture of best-in-class nanoparticles for use as medicines, and in medical research, announced that Mr. Andrew Booth, Vice President & General Manager, Instrumen...

Read More

Press Release

Precision NanoSystems, Inc. (PNI), a privately held biotechnology company developing proprietary microfluidic-based manufacturing technology for the use and development of cutting edge nanomedicines, today announced it has been awarded a position i...

Read More